SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001176256-08-000469
Filing Date
2008-04-10
Accepted
2008-04-10 15:56:44
Documents
1
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 21492
  Complete submission text file 0001176256-08-000469.txt   23167
Mailing Address
Business Address 1618 STATION STREET VANCOUVER A1 V6A 1B6
ANGIOTECH PHARMACEUTICALS INC (Issuer) CIK: 0001096481 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O VIA PHARMACEUTICALS, INC 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address 415-283-2200
HOWARD DAVID T (Reporting) CIK: 0001263438 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30334 | Film No.: 08750049